BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 36641322)

  • 21. Cytotoxic T-lymphocyte antigen-4 inhibits GATA-3 but not T-bet mRNA expression during T helper cell differentiation.
    Nasta F; Ubaldi V; Pace L; Doria G; Pioli C
    Immunology; 2006 Mar; 117(3):358-67. PubMed ID: 16476055
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Shenghua Decoction reduces uterine bleeding and regulates T-cell paradigm in human deciduas of RU486 medical abortion.
    Li X; Zhang M; Wang B; Li Y; Wang L; Zhao X; Zhou X; Guo Y; Jiang G; Yao C
    J Ethnopharmacol; 2013 Dec; 150(3):907-17. PubMed ID: 24140602
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The immunomodulatory role of tumor Syndecan-1 (CD138) on ex vivo tumor microenvironmental CD4+ T cell polarization in inflammatory and non-inflammatory breast cancer patients.
    Saleh ME; Gadalla R; Hassan H; Afifi A; Götte M; El-Shinawi M; Mohamed MM; Ibrahim SA
    PLoS One; 2019; 14(5):e0217550. PubMed ID: 31145753
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Involvement of Xeroderma Pigmentosum Complementation Group G (XPG) in epigenetic regulation of T-Helper (T
    Pal R; Rakshit S; Shanmugam G; Paul N; Bhattacharya D; Chatterjee A; Singh A; George M; Sarkar K
    Immunobiology; 2022 Sep; 227(5):152259. PubMed ID: 36037675
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A rapid flow cytometric assay to detect CD4+ and CD8+ T-helper (Th) 0, Th1 and Th2 cells in whole blood and its application to study cytokine levels in atopic dermatitis before and after cyclosporin therapy.
    Farrell AM; Antrobus P; Simpson D; Powell S; Chapel HM; Ferry BL
    Br J Dermatol; 2001 Jan; 144(1):24-33. PubMed ID: 11167679
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of T helper cell cytokine expression: functional dichotomy of antigen-presenting cells.
    Schmitz J; Assenmacher M; Radbruch A
    Eur J Immunol; 1993 Jan; 23(1):191-9. PubMed ID: 8419171
    [TBL] [Abstract][Full Text] [Related]  

  • 27. T helper responses are maintained by basal-like breast cancer cells and confer to immune modulation via upregulation of PD-1 ligands.
    Karasar P; Esendagli G
    Breast Cancer Res Treat; 2014 Jun; 145(3):605-14. PubMed ID: 24816762
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differentiation and Regulation of T
    Basu A; Ramamoorthi G; Albert G; Gallen C; Beyer A; Snyder C; Koski G; Disis ML; Czerniecki BJ; Kodumudi K
    Front Immunol; 2021; 12():669474. PubMed ID: 34012451
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Type 1 T helper and type 2 T helper cells: functions, regulation and role in protection and disease.
    Romagnani S
    Int J Clin Lab Res; 1991; 21(2):152-8. PubMed ID: 1687725
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Suppression of ongoing experimental autoimmune myasthenia gravis by transfer of RelB-silenced bone marrow dentritic cells is associated with a change from a T helper Th17/Th1 to a Th2 and FoxP3+ regulatory T-cell profile.
    Yang H; Zhang Y; Wu M; Li J; Zhou W; Li G; Li X; Xiao B; Christadoss P
    Inflamm Res; 2010 Mar; 59(3):197-205. PubMed ID: 19768385
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma.
    Liyanage UK; Moore TT; Joo HG; Tanaka Y; Herrmann V; Doherty G; Drebin JA; Strasberg SM; Eberlein TJ; Goedegebuure PS; Linehan DC
    J Immunol; 2002 Sep; 169(5):2756-61. PubMed ID: 12193750
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distinct subsets of accessory cells activate Thy-1+ triple negative (CD3-, CD4-, CD8-) cells and Th-1 delayed-type hypersensitivity effector T cells.
    Matsushima GK; Stohlman SA
    J Immunol; 1991 May; 146(10):3322-31. PubMed ID: 1673982
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Helios is associated with CD4 T cells differentiating to T helper 2 and follicular helper T cells in vivo independently of Foxp3 expression.
    Serre K; Bénézech C; Desanti G; Bobat S; Toellner KM; Bird R; Chan S; Kastner P; Cunningham AF; Maclennan IC; Mohr E
    PLoS One; 2011; 6(6):e20731. PubMed ID: 21677778
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Disease-associated bias in T helper type 1 (Th1)/Th2 CD4(+) T cell responses against MAGE-6 in HLA-DRB10401(+) patients with renal cell carcinoma or melanoma.
    Tatsumi T; Kierstead LS; Ranieri E; Gesualdo L; Schena FP; Finke JH; Bukowski RM; Mueller-Berghaus J; Kirkwood JM; Kwok WW; Storkus WJ
    J Exp Med; 2002 Sep; 196(5):619-28. PubMed ID: 12208877
    [TBL] [Abstract][Full Text] [Related]  

  • 35. T helper 1/T helper 2 cytokine imbalance in respiratory syncytial virus infection is associated with increased endogenous plasma cortisol.
    Pinto RA; Arredondo SM; Bono MR; Gaggero AA; Díaz PV
    Pediatrics; 2006 May; 117(5):e878-86. PubMed ID: 16618789
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Generation of mammaglobin-A-specific CD4 T cells and identification of candidate CD4 epitopes for breast cancer vaccine strategies.
    Viehl CT; Frey DM; Phommaly C; Chen T; Fleming TP; Gillanders WE; Eberlein TJ; Goedegebuure PS
    Breast Cancer Res Treat; 2008 May; 109(2):305-14. PubMed ID: 17653857
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The generation of both T killer and Th cell clones specific for the tumor-associated antigen HER2 using retrovirally transduced dendritic cells.
    zum Büschenfelde CM; Metzger J; Hermann C; Nicklisch N; Peschel C; Bernhard H
    J Immunol; 2001 Aug; 167(3):1712-9. PubMed ID: 11466395
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effective antigen presentation to helper T cells by human eosinophils.
    Farhan RK; Vickers MA; Ghaemmaghami AM; Hall AM; Barker RN; Walsh GM
    Immunology; 2016 Dec; 149(4):413-422. PubMed ID: 27502559
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human tumor antigen-specific helper and regulatory T cells share common epitope specificity but exhibit distinct T cell repertoire.
    Fourcade J; Sun Z; Kudela P; Janjic B; Kirkwood JM; El-Hafnawy T; Zarour HM
    J Immunol; 2010 Jun; 184(12):6709-18. PubMed ID: 20483736
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Simultaneous production of T helper-1-like cytokines and cytolytic activity by tumor-specific T cells in ovarian and breast cancer.
    Goedegebuure PS; Douville CC; Doherty JM; Linehan DC; Lee KY; Ganguly EK; Eberlein TJ
    Cell Immunol; 1997 Feb; 175(2):150-6. PubMed ID: 9023420
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.